321 related articles for article (PubMed ID: 18676862)
1. Tumor-associated MICA is shed by ADAM proteases.
Waldhauer I; Goehlsdorf D; Gieseke F; Weinschenk T; Wittenbrink M; Ludwig A; Stevanovic S; Rammensee HG; Steinle A
Cancer Res; 2008 Aug; 68(15):6368-76. PubMed ID: 18676862
[TBL] [Abstract][Full Text] [Related]
2. Shedding of endogenous MHC class I-related chain molecules A and B from different human tumor entities: heterogeneous involvement of the "a disintegrin and metalloproteases" 10 and 17.
Chitadze G; Lettau M; Bhat J; Wesch D; Steinle A; Fürst D; Mytilineos J; Kalthoff H; Janssen O; Oberg HH; Kabelitz D
Int J Cancer; 2013 Oct; 133(7):1557-66. PubMed ID: 23526433
[TBL] [Abstract][Full Text] [Related]
3. Proteolytic release of soluble UL16-binding protein 2 from tumor cells.
Waldhauer I; Steinle A
Cancer Res; 2006 Mar; 66(5):2520-6. PubMed ID: 16510567
[TBL] [Abstract][Full Text] [Related]
4. Anticancer chemotherapy inhibits MHC class I-related chain a ectodomain shedding by downregulating ADAM10 expression in hepatocellular carcinoma.
Kohga K; Takehara T; Tatsumi T; Miyagi T; Ishida H; Ohkawa K; Kanto T; Hiramatsu N; Hayashi N
Cancer Res; 2009 Oct; 69(20):8050-7. PubMed ID: 19826051
[TBL] [Abstract][Full Text] [Related]
5. Disulphide-isomerase-enabled shedding of tumour-associated NKG2D ligands.
Kaiser BK; Yim D; Chow IT; Gonzalez S; Dai Z; Mann HH; Strong RK; Groh V; Spies T
Nature; 2007 May; 447(7143):482-6. PubMed ID: 17495932
[TBL] [Abstract][Full Text] [Related]
6. TGF-beta and metalloproteinases differentially suppress NKG2D ligand surface expression on malignant glioma cells.
Eisele G; Wischhusen J; Mittelbronn M; Meyermann R; Waldhauer I; Steinle A; Weller M; Friese MA
Brain; 2006 Sep; 129(Pt 9):2416-25. PubMed ID: 16891318
[TBL] [Abstract][Full Text] [Related]
7. Release of MICB molecules by tumor cells: mechanism and soluble MICB in sera of cancer patients.
Salih HR; Goehlsdorf D; Steinle A
Hum Immunol; 2006 Mar; 67(3):188-95. PubMed ID: 16698441
[TBL] [Abstract][Full Text] [Related]
8. Soluble MICB in malignant diseases: analysis of diagnostic significance and correlation with soluble MICA.
Holdenrieder S; Stieber P; Peterfi A; Nagel D; Steinle A; Salih HR
Cancer Immunol Immunother; 2006 Dec; 55(12):1584-9. PubMed ID: 16636811
[TBL] [Abstract][Full Text] [Related]
9. MMP9 mediates MICA shedding in human osteosarcomas.
Sun D; Wang X; Zhang H; Deng L; Zhang Y
Cell Biol Int; 2011 Jun; 35(6):569-74. PubMed ID: 21143201
[TBL] [Abstract][Full Text] [Related]
10. Relationship between soluble MICA and the MICA A5.1 homozygous genotype in patients with oral squamous cell carcinoma.
Tamaki S; Kawakami M; Yamanaka Y; Shimomura H; Imai Y; Ishida J; Yamamoto K; Ishitani A; Hatake K; Kirita T
Clin Immunol; 2009 Mar; 130(3):331-7. PubMed ID: 18951065
[TBL] [Abstract][Full Text] [Related]
11. Sodium butyrate upregulates expression of NKG2D ligand MICA/B in HeLa and HepG2 cell lines and increases their susceptibility to NK lysis.
Zhang C; Wang Y; Zhou Z; Zhang J; Tian Z
Cancer Immunol Immunother; 2009 Aug; 58(8):1275-85. PubMed ID: 19139882
[TBL] [Abstract][Full Text] [Related]
12. Prevalent expression of MHC class I chain-related molecule A in human osteosarcoma.
Lu SM; Xiao P; Xue L; Che LH; Yang P; Li Y; Qiao H
Neoplasma; 2008; 55(3):266-72. PubMed ID: 18348660
[TBL] [Abstract][Full Text] [Related]
13. The membrane type matrix metalloproteinase MMP14 mediates constitutive shedding of MHC class I chain-related molecule A independent of A disintegrin and metalloproteinases.
Liu G; Atteridge CL; Wang X; Lundgren AD; Wu JD
J Immunol; 2010 Apr; 184(7):3346-50. PubMed ID: 20208009
[TBL] [Abstract][Full Text] [Related]
14. NKG2D ligands expression and NKG2D-mediated cytotoxicity in human laryngeal squamous carcinoma cells.
Chen XM; Xu XQ; Sun K; Hallett WH; Zhao JD; Zhang DL
Scand J Immunol; 2008 May; 67(5):441-7. PubMed ID: 18312485
[TBL] [Abstract][Full Text] [Related]
15. Expression of major histocompatibility complex class I chain-related molecule A, NKG2D, and transforming growth factor-beta in the liver of humans with alveolar echinococcosis: new actors in the tolerance to parasites?
Zhang S; Hüe S; Sène D; Penfornis A; Bresson-Hadni S; Kantelip B; Caillat-Zucman S; Vuitton DA
J Infect Dis; 2008 May; 197(9):1341-9. PubMed ID: 18422447
[TBL] [Abstract][Full Text] [Related]
16. Differential clinical significance of individual NKG2D ligands in melanoma: soluble ULBP2 as an indicator of poor prognosis superior to S100B.
Paschen A; Sucker A; Hill B; Moll I; Zapatka M; Nguyen XD; Sim GC; Gutmann I; Hassel J; Becker JC; Steinle A; Schadendorf D; Ugurel S
Clin Cancer Res; 2009 Aug; 15(16):5208-15. PubMed ID: 19671853
[TBL] [Abstract][Full Text] [Related]
17. TNK cells (NKG2D+ CD8+ or CD4+ T lymphocytes) in the control of human tumors.
Maccalli C; Scaramuzza S; Parmiani G
Cancer Immunol Immunother; 2009 May; 58(5):801-8. PubMed ID: 19089424
[TBL] [Abstract][Full Text] [Related]
18. Heat shock protein-90 inhibitors increase MHC class I-related chain A and B ligand expression on multiple myeloma cells and their ability to trigger NK cell degranulation.
Fionda C; Soriani A; Malgarini G; Iannitto ML; Santoni A; Cippitelli M
J Immunol; 2009 Oct; 183(7):4385-94. PubMed ID: 19748980
[TBL] [Abstract][Full Text] [Related]
19. Matrix metallopeptidase 2 (MMP2) mediates MHC class I polypeptide-related sequence A (MICA) shedding in renal cell carcinoma.
Yang FQ; Liu M; Yang FP; Zhang XL; Yang B; Guo CC; Huang JH; Che JP; Yan Y; Zheng JH
Actas Urol Esp; 2014 Apr; 38(3):172-8. PubMed ID: 24461475
[TBL] [Abstract][Full Text] [Related]
20. Genotoxic Stress Induces Senescence-Associated ADAM10-Dependent Release of NKG2D MIC Ligands in Multiple Myeloma Cells.
Zingoni A; Cecere F; Vulpis E; Fionda C; Molfetta R; Soriani A; Petrucci MT; Ricciardi MR; Fuerst D; Amendola MG; Mytilineos J; Cerboni C; Paolini R; Cippitelli M; Santoni A
J Immunol; 2015 Jul; 195(2):736-48. PubMed ID: 26071561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]